arabinofuranosylcytosine triphosphate and Kahler Disease

arabinofuranosylcytosine triphosphate has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexanian, R; Barlogie, B; Dreicer, R; Kantarjian, H; Plunkett, W1

Other Studies

1 other study(ies) available for arabinofuranosylcytosine triphosphate and Kahler Disease

ArticleYear
High-dose cytosine arabinoside in multiple myeloma.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:2

    Topics: Aged; Arabinofuranosylcytosine Triphosphate; Blood Cell Count; Bone Marrow; Bone Marrow Diseases; Cell Count; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Interphase; Male; Middle Aged; Multiple Myeloma

1984